Comoros vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Comoros
100.0%
in 2023
South-East Asia (WHO region)
94.0%
in 2024
Comoros rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Comoros
- South-East Asia (WHO region)
How they compare
Comoros currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Comoros's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 11 shared years of data; in 2005 it was Comoros ahead.
Comoros ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Comoros has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Comoros | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 5.6% | 94.4% | Comoros |
| 2010s | 100.0% | 76.5% | 23.5% | Comoros |
| 2020s | 91.8% | 91.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Comoros or South-East Asia (WHO region)?
- Comoros, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Comoros and South-East Asia (WHO region)?
- 6.0%, with Comoros ahead.
- How many years of comparable data are there for Comoros and South-East Asia (WHO region)?
- 11 years are reported by both, from 2005 to 2023.
- How do Comoros and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Comoros ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.